|Day Low/High||107.30 / 109.71|
|52 Wk Low/High||94.36 / 137.95|
Stocks hold onto solid gains by mid-morning Tuesday after new home sales hit an eight-year high.
U.S. futures were rising across the board on Tuesday while crude prices experienced a decline.
The two companies are still working with anti-trust regulators on the $44.7 billion deal.
Healthcare and life science drive second-quarter growth.
Good pharmaceuticals results mask weak crop science results that could be used to justify a new run at Monsanto.
Overall revenue for the Monsanto bidder falls short of expectations.
The German chemicals company sticks with its forecast for a slight fall in full-year operating profit and a significant decline in sales.
Results from the ChemChina bid target come on the heels of disappointing figures from former suitor Monsanto.
It was the tale of two earnings seasons on Tuesday and Wall Street was stuck in the middle.
Stocks fluctuate late Tuesday as earnings reports are mixed.
Aetna and Humana each traded down sharply as antitrust hurdles may block $34 billion merger.
IMF cuts growth estimates for the U.K. by almost 1 percentage point for 2017.
A rush of earnings kept investors busy throughout the morning. Netflix was one of the biggest drags on the Nasdaq and S&P 500.
Stocks are off session lows by mid-morning Tuesday with the Dow Jones Industrial Average trying for gains after a rush of key earnings.
The chemicals giant grew revenues in every division and upped its bid for U.S.-based Monsanto this week.
A huge break fee and debt financing might convince Monsanto to open its books but the German bidder probably won't dig much deeper.
The S&P 500 closed out Thursday's session with its fourth record close in a row as hopes for global monetary stimulus kept hopes high on Wall Street.
What a week. The S&P 500 closed out Thursday's session with its fourth record close in a row as hopes for global monetary stimulus kept hopes high on Wall Street.
The S&P 500 comes off session highs by Thursday afternoon, though remains on track for a record close for the fourth time this week.
Shares in the potential German seller rise sharply, despite some suspicions the talks are a negotiating ruse by the St. Louis company.
U.K.’s June 23 referendum on its relationship with the European Union sends jitters through markets across the globe
Shell pulls up the FTSE 100 on new cost-cutting plans.
Brussels statisticians raise their estimate of first-quarter eurozone growth, while Shell promises more cost cuts following its BG purchase.
ECB president Mario Draghi said that growth in euro area will be muted for the time being.
It took some time but Wall Street eventually got used to the higher prospects for a June rate hike this week.
Marks & Spencer falls as a pretax profit slump offsets a higher dividend payment, while Bayer vows to press on with its pursuit of Monsanto.
U.S. stocks rocketed higher as the fears over rate hikes that have plagued Wall Street for nearly a week began to fade on Tuesday.
Who's afraid of the big, bad Fed? Not Wall Street. Not anymore.